356 related articles for article (PubMed ID: 17768598)
1. Targeting endothelial and tumor cells with semaphorins.
Bielenberg DR; Klagsbrun M
Cancer Metastasis Rev; 2007 Dec; 26(3-4):421-31. PubMed ID: 17768598
[TBL] [Abstract][Full Text] [Related]
2. Role of class 3 semaphorins and their receptors in tumor growth and angiogenesis.
Gaur P; Bielenberg DR; Samuel S; Bose D; Zhou Y; Gray MJ; Dallas NA; Fan F; Xia L; Lu J; Ellis LM
Clin Cancer Res; 2009 Nov; 15(22):6763-70. PubMed ID: 19887479
[TBL] [Abstract][Full Text] [Related]
3. Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis.
Geretti E; Shimizu A; Klagsbrun M
Angiogenesis; 2008; 11(1):31-9. PubMed ID: 18283547
[TBL] [Abstract][Full Text] [Related]
4. Neuropilins in neoplasms: expression, regulation, and function.
Bielenberg DR; Pettaway CA; Takashima S; Klagsbrun M
Exp Cell Res; 2006 Mar; 312(5):584-93. PubMed ID: 16445911
[TBL] [Abstract][Full Text] [Related]
5. Class 3 semaphorin signaling: the end of a dogma.
Potiron V; Roche J
Sci STKE; 2005 May; 2005(285):pe24. PubMed ID: 15914725
[TBL] [Abstract][Full Text] [Related]
6. Neuropilins in physiological and pathological angiogenesis.
Staton CA; Kumar I; Reed MW; Brown NJ
J Pathol; 2007 Jul; 212(3):237-48. PubMed ID: 17503412
[TBL] [Abstract][Full Text] [Related]
7. The neuropilins and their role in tumorigenesis and tumor progression.
Guttmann-Raviv N; Kessler O; Shraga-Heled N; Lange T; Herzog Y; Neufeld G
Cancer Lett; 2006 Jan; 231(1):1-11. PubMed ID: 16356825
[TBL] [Abstract][Full Text] [Related]
8. Neuropilin-VEGF signaling pathway acts as a key modulator of vascular, lymphatic, and inflammatory cell responses of the bladder to intravesical BCG treatment.
Saban MR; Sferra TJ; Davis CA; Simpson C; Allen A; Maier J; Fowler B; Knowlton N; Birder L; Wu XR; Saban R
Am J Physiol Renal Physiol; 2010 Dec; 299(6):F1245-56. PubMed ID: 20861073
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor receptors: expression and function in solid tumors.
Wey JS; Stoeltzing O; Ellis LM
Clin Adv Hematol Oncol; 2004 Jan; 2(1):37-45. PubMed ID: 16163158
[TBL] [Abstract][Full Text] [Related]
10. Class 3 semaphorins and their receptors in physiological and pathological angiogenesis.
Staton CA
Biochem Soc Trans; 2011 Dec; 39(6):1565-70. PubMed ID: 22103488
[TBL] [Abstract][Full Text] [Related]
11. Semaphorin 3E, an exception to the rule.
Klagsbrun M; Shimizu A
J Clin Invest; 2010 Aug; 120(8):2658-60. PubMed ID: 20664165
[TBL] [Abstract][Full Text] [Related]
12. Semaphorin-4A, an activator for T-cell-mediated immunity, suppresses angiogenesis via Plexin-D1.
Toyofuku T; Yabuki M; Kamei J; Kamei M; Makino N; Kumanogoh A; Hori M
EMBO J; 2007 Mar; 26(5):1373-84. PubMed ID: 17318185
[TBL] [Abstract][Full Text] [Related]
13. Semaphorin-induced cytoskeletal collapse and repulsion of endothelial cells.
Bielenberg DR; Shimizu A; Klagsbrun M
Methods Enzymol; 2008; 443():299-314. PubMed ID: 18772022
[TBL] [Abstract][Full Text] [Related]
14. Roles of neuropilins in neuronal development, angiogenesis, and cancers.
Chen C; Li M; Chai H; Yang H; Fisher WE; Yao Q
World J Surg; 2005 Mar; 29(3):271-5. PubMed ID: 15696396
[TBL] [Abstract][Full Text] [Related]
15. Targeting tumor angiogenesis.
Gaur P; Bose D; Samuel S; Ellis LM
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S12-9. PubMed ID: 19393831
[TBL] [Abstract][Full Text] [Related]
16. Neuropilins: novel targets for anti-angiogenesis therapies.
Geretti E; Klagsbrun M
Cell Adh Migr; 2007; 1(2):56-61. PubMed ID: 19329879
[TBL] [Abstract][Full Text] [Related]
17. Function of members of the neuropilin family as essential pleiotropic cell surface receptors.
Parker MW; Guo HF; Li X; Linkugel AD; Vander Kooi CW
Biochemistry; 2012 Nov; 51(47):9437-46. PubMed ID: 23116416
[TBL] [Abstract][Full Text] [Related]
18. Neuropilin signalling in angiogenesis.
Koch S
Biochem Soc Trans; 2012 Feb; 40(1):20-5. PubMed ID: 22260660
[TBL] [Abstract][Full Text] [Related]
19. Semaphorin signaling in cancer cells and in cells of the tumor microenvironment--two sides of a coin.
Capparuccia L; Tamagnone L
J Cell Sci; 2009 Jun; 122(Pt 11):1723-36. PubMed ID: 19461072
[TBL] [Abstract][Full Text] [Related]
20. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth.
Pan Q; Chanthery Y; Liang WC; Stawicki S; Mak J; Rathore N; Tong RK; Kowalski J; Yee SF; Pacheco G; Ross S; Cheng Z; Le Couter J; Plowman G; Peale F; Koch AW; Wu Y; Bagri A; Tessier-Lavigne M; Watts RJ
Cancer Cell; 2007 Jan; 11(1):53-67. PubMed ID: 17222790
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
